To define OAS2 as a potential psoriasis biomarker, the serum level of OAS2 detected by ELISA was significantly higher in psoriasis patients (n = 32) than in healthy controls (HC, n = 26) (P < 0.0001, Figure 3D). This evidence concerns the gene OAS2 and psoriasis.